
Shanghai United Imaging Healthcare Co., Ltd.
United Imaging
United Imaging Healthcare is China's leading high-end medical imaging company, founded in 2011 and headquartered in Shanghai. The company was established with the explicit mission of breaking the global monopoly of the "GPS" trio (GE HealthCare, Philips, Siemens Healthineers) in advanced imaging, and has achieved full self-developed control over superconducting magnets, gradient coils, and high-end PET/CT systems. In FY2025, United Imaging generated CNY 13.80 billion in revenue, up 33.98% year-on-year, with net profit attributable to shareholders of CNY 1.87 billion, up 48.14%. The company employs 8,173 people, of whom a high proportion are R&D staff, with CNY 2.62 billion invested in R&D in 2025 (approximately 19% of revenue) — one of the highest R&D intensities in the medical device industry. United Imaging ships its products to more than 100 countries and regions, with overseas revenue reaching CNY 3.43 billion, up 51.39% year-on-year.
Strengths: United Imaging has built China's only complete high-end imaging portfolio spanning MRI, CT, PET/CT, PET/MR, X-ray, and radiation therapy (RT) systems. Its uEXPLORER total-body PET/CT, developed with UC Davis, achieved global recognition as the world's first total-body scanner. The company's R&D intensity of ~19% of revenue exceeds most Western peers, driving rapid product iteration across superconducting magnet and detector technologies. Overseas revenue growth above 51% demonstrates accelerating global acceptance of Chinese imaging technology, particularly in Europe, the Middle East, and Southeast Asia.
Weaknesses: United Imaging's overall revenue scale remains far below the global incumbents — CNY 13.8 billion versus GE HealthCare's USD 20.6 billion — limiting its R&D budget in absolute terms. The company faces domestic headwinds from China's anti-corruption campaign and VBP procurement reforms, which have pressured public hospital purchasing. As a relative newcomer, United Imaging's installed base and brand trust in mature Western markets remain limited, requiring sustained investment to displace entrenched competitors.Read MoreShow Less
Strengths: United Imaging has built China's only complete high-end imaging portfolio spanning MRI, CT, PET/CT, PET/MR, X-ray, and radiation therapy (RT) systems. Its uEXPLORER total-body PET/CT, developed with UC Davis, achieved global recognition as the world's first total-body scanner. The company's R&D intensity of ~19% of revenue exceeds most Western peers, driving rapid product iteration across superconducting magnet and detector technologies. Overseas revenue growth above 51% demonstrates accelerating global acceptance of Chinese imaging technology, particularly in Europe, the Middle East, and Southeast Asia.
Weaknesses: United Imaging's overall revenue scale remains far below the global incumbents — CNY 13.8 billion versus GE HealthCare's USD 20.6 billion — limiting its R&D budget in absolute terms. The company faces domestic headwinds from China's anti-corruption campaign and VBP procurement reforms, which have pressured public hospital purchasing. As a relative newcomer, United Imaging's installed base and brand trust in mature Western markets remain limited, requiring sustained investment to displace entrenched competitors.
Listed market data
688271 · SSE · weeklyHistory →- Market cap
- $14.4 B
- Share price
- CNY 117.04
- 1Y change
- -18.2%
- Recent change
- -1.2%
- Since first close
- -35.4%
- Revenue (TTM)
- CNY$13.8 B (FY2025)
11-19 → 11-20
from 2022
Financial history
Full market history- 2026-11CNY 117.04$14.4 B+1.8%
- 2026-10CNY 115.00$14.2 B+7.1%
- 2026-09CNY 107.37$13.3 B+2.7%
- 2026-08CNY 104.50$12.9 B-9.5%
- 2026-07CNY 115.52$14.3 B+14.1%
- 2026-06CNY 101.23$12.5 B-15.9%
- 2026-05CNY 120.30$14.8 B+9.4%
- 2026-04CNY 109.95$13.6 B-1.8%
- 2026-03CNY 112.00$13.8 B-14.3%
- 2026-02CNY 130.70$16.1 B+1.1%
- 2026-01CNY 129.30$16 B+3.0%
- 2025-12CNY 125.50$15.5 B—
Ownership & Control
Latest available filings- Controlling entity
- Publicly held — no controlling shareholder disclosed
- Company type
- Brand & Manufacturer
- Insiders
- 56.59%
- Institutions
- 9.75%(218 holders)
- Free float
- 22.47%
Percentages are of total shares outstanding, aggregated from 13F-style filings via Yahoo Finance. Institutional figures reflect US-filed positions and may undercount owners filing elsewhere. No figure is shown where none is disclosed.
In the press
All coverage →5 latest headlines2- Longer FOV, faster scans: United Imaging at EANM 2026 - healthcare-in-europe.comhealthcare-in-europe.com2026-10-20
- Price to earnings forward of Shanghai United Imaging Healthcare Co., Ltd. Class A – SSE:688271 - TradingViewwww.tradingview.com2026-10-10
- Shanghai United Imaging Healthcare Co., Ltd. Announces Recall of Positron Emission Tomography and Computed Tomography System Model Umi Panorama Gs with Software - www.marketscreener.comwww.marketscreener.com2026-10-09
- FDA announces recall of United Imaging CT scanner over software issue - DOTmedwww.dotmed.com2026-10-01
- United Imaging Intelligence not undertaking an "extreme" AI rollout, says co-CEO - Reuterswww.reuters.com2026-07-20
• uMR superconducting MRI 1.5T, 3.0T, 5.0T
• Ultra-high-field research platforms
CT Systems – Core Business
• uCT computed tomography and spectral CT
• Mobile CT for emergency and surgical use
Molecular Imaging – Core Business
• uMI PET/CT and uEXPLORER total-body PET/CT
• uPMR PET/MR systems
X-Ray & Angiography – Core Business
• uDR digital radiography
• Mobile C-arm and angiography systems
Radiation Therapy & AI – Core Business
• uRT-linac radiotherapy and IGRT
• uAI medical imaging AI platform and cloud diagnostics
Annual and interim reports published by the exchange or regulator. Links open the official source — files are not hosted on VerityRank.
| Year | Filing | Filed | Source | |
|---|---|---|---|---|
| — | Official disclosure search | — | SSE | Open ↗ |
Links point to the issuer’s official disclosure platform. We store no filings.
Quick Facts
Headquarters
Founded
Employees
Revenue
Market cap
Factories
Presence
Listing
SSE STAR Market: 688271Categories
15 categories · scroll for more
Related
Similar listed companies
- Eli Lilly and Company· $1.3 T
- Johnson & Johnson (J&J)· $651 B
- Allergan Aesthetics· $506 B
- AbbVie Inc.· $506 B
- ASML Holding N.V.· $488 B
- F. Hoffmann-La Roche AG· $375 B
Data Sources & Methodology
This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.
VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.
Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.
Key references: Official Website SSE STAR Market: 688271 , United Imaging News Center (Official)
United Imaging 2025 Annual Report & Q1 2026 Results (PR Newswire)
United Imaging Q3 2025 Results — Overseas Revenue Up 42% (PR Newswire)
Shanghai United Imaging Healthcare Investor Summary (Quartr)
